AxoGen, Inc. (AXGN) Stock Forecast
Data as of Oct 31, 2026Healthcare · Current price $49.19 (-0.90%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Feb 23, 2026 | Jayson Bedford | Raymond James | $41.00 | -16.6% |
| Dec 4, 2025 | Jayson Bedford | Raymond James | $36.00 | -26.8% |
| Dec 4, 2025 | Frank Takkinen | Lake Street | $40.00 | -18.7% |
| Sep 30, 2025 | Yi Chen | H.C. Wainwright | $25.00 | -49.2% |
Top Analysts Covering AXGN
AXGN vs Sector & Market
| Metric | AXGN | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.00 | 2.25 | 2.41 |
| Analyst Count | 12 | 8 | 19 |
| Target Upside | +18.2% | +153002.0% | +21.5% |
| P/E Ratio | -68.88 | 3.53 | 38.49 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $70M | $71M | $72M | 5 |
| 2027-03-31 | $67M | $68M | $68M | 3 |
| 2027-06-30 | $76M | $77M | $78M | 3 |
| 2027-09-30 | $80M | $81M | $82M | 3 |
| 2027-12-31 | $82M | $82M | $83M | 3 |
| 2028-12-31 | $365M | $366M | $367M | 4 |
| 2029-12-31 | $421M | $425M | $429M | 3 |
| 2030-12-31 | $527M | $532M | $537M | 3 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $0.15 | $0.15 | $0.16 | 2 |
| 2027-03-31 | $0.16 | $0.16 | $0.17 | 2 |
| 2027-06-30 | $0.20 | $0.20 | $0.20 | 1 |
| 2027-09-30 | $0.22 | $0.22 | $0.22 | 1 |
| 2027-12-31 | $0.23 | $0.23 | $0.24 | 2 |
| 2028-12-31 | $0.18 | $0.97 | $2.51 | 3 |
| 2029-12-31 | $1.26 | $1.28 | $1.29 | 1 |
| 2030-12-31 | $1.78 | $1.80 | $1.82 | 1 |
Frequently Asked Questions
What is the analyst consensus for AXGN?
The consensus among 12 analysts covering AxoGen, Inc. (AXGN) is Buy with an average price target of $52.80.
What is the highest price target for AXGN?
The highest price target for AXGN is $41.00, set by Jayson Bedford at Raymond James on 2026-02-23.
What is the lowest price target for AXGN?
The lowest price target for AXGN is $25.00, set by Yi Chen at H.C. Wainwright on 2025-09-30.
How many analysts cover AXGN?
12 analysts have issued ratings for AxoGen, Inc. in the past 12 months.
Is AXGN a buy or sell right now?
Based on 12 analyst ratings, AXGN has a consensus rating of Buy (2.00/5) with a +18.2% upside to the consensus target of $52.80.
What are the earnings estimates for AXGN?
Analysts estimate AXGN will report EPS of $0.15 for the period ending 2026-12-31, with revenue estimated at $71M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.